Our understanding of signal transduction in cells of the immune system was greatly advanced during the 1990s when it was shown that B cell receptors (BCRs), T cell receptors (TCRs) and Fc receptors (FcRs) (collectively termed classical immunoreceptors) signal by a conceptually similar mechanism. All these receptors associate with transmembrane proteins that have cytoplasmic domains containing immunoreceptor tyrosine-based activation motifs (ITAMs) 1 , which are short peptide sequences with two tyrosine residues that are 6-12 amino acids apart. ITAM tyrosine residues are rapidly phosphorylated following receptor engagement, leading to the recruitment and activation of spleen tyrosine kinase (SYK) or the related protein ζ-chain-associated protein kinase of 70 kDa (ZAP70). This signalling model soon entered immunology textbooks and became the central paradigm of immune cell signalling.
Our understanding of signal transduction in cells of the immune system was greatly advanced during the 1990s when it was shown that B cell receptors (BCRs), T cell receptors (TCRs) and Fc receptors (FcRs) (collectively termed classical immunoreceptors) signal by a conceptually similar mechanism. All these receptors associate with transmembrane proteins that have cytoplasmic domains containing immunoreceptor tyrosine-based activation motifs (ITAMs) 1 , which are short peptide sequences with two tyrosine residues that are 6-12 amino acids apart. ITAM tyrosine residues are rapidly phosphorylated following receptor engagement, leading to the recruitment and activation of spleen tyrosine kinase (SYK) or the related protein ζ-chain-associated protein kinase of 70 kDa (ZAP70). This signalling model soon entered immunology textbooks and became the central paradigm of immune cell signalling.
SYK is a 72 kDa non-receptor tyrosine kinase that contains two SRC homology 2 (SH2) domains and a kinase domain (BOX 1) and is most highly expressed by haematopoietic cells. Mammals also express a SYK homologue, ZAP70, which is mostly restricted to T cells and natural killer (NK) cells. SYK-related kinases are also found in invertebrates. Further information about SYK and SYK-related molecules can be found in BOX 1.
The SYK signalling pathway was initially thought to be restricted to classical immunoreceptors of the adaptive immune response. However, later studies showing that glycoprotein VI (GPVI), a collagen receptor expressed by platelets, also signals by a similar mechanism 2 and that the petechiated appearance of SYK-deficient embryos was due to a defect in lymphatic vascular development 3 provided evidence of a role for SYK beyond the adaptive immune response. The discovery of ITAM-based signalling in Drosophila melanogaster 4 also indicated a role for such pathways beyond adaptive immunity (insects do not have an adaptive immune system). Additional studies have revealed that SYK is required for several functions of innate immune cells and for certain non-immune functions, such as bone resorption by osteoclasts 5 . SYK has also been shown to mediate signalling by classes of receptors, including integrins 6 and C-type lectins 7 , that do not contain conventional ITAMs. Collectively, these studies have dramatically changed our view of the SYK tyrosine kinase. This Review summarizes our current understanding of the diverse roles of SYK, in both immune and non-immune biological responses, and describes how this knowledge is being translated for the therapy of human diseases.
ITAM-and hemITAM-based signalling pathways
Classical immunoreceptors (BCRs, TCRs and various FcRs) mediate, either directly or indirectly, the adaptive recognition of self and foreign antigens. Immunoreceptor-associated transmembrane adaptors or, in the case of FcγRIIA, the ligand binding receptor chain itself contain one or more ITAMs (FIG. 1a) , and receptor ligation leads to the phosphorylation of these ITAMs, primarily by members of the SRC tyrosine kinase family. Through interaction with their tandem SH2 domains, dual-phosphorylated ITAMs recruit SYK, in the case of the BCR and FcR, or ZAP70, in the case of Immunoreceptor tyrosinebased activation motif (ITAM) . A short peptide motif containing two tyrosine residues that is found in the cytoplasmic tail of several signalling adaptor proteins and is necessary to recruit proteins that are involved in triggering activating signalling proteins. The consensus sequence is Tyr-X-X-(Leu/Ile)-X 6-12 -Tyr-X-X-(Leu/Ile), where X denotes any amino acid.
Glycoprotein VI (GPVI) . One of several collagen receptors expressed on platelets. GPVI is a transmembrane glycoprotein that is closely related to Fcα receptors (FcαRs). It associates with, and signals through, the ITAM-containing adaptor FcR γ-chain.
Petechia
A small red spot on the skin that results from localized bleeding owing to broken blood vessels. A large number of petechiae usually indicates a platelet defect. Note that, in contrast to the original assumptions, the red spots of SYK-deficient embryos are not bona fide petechiae as they are caused by a vascular developmental defect.
Osteoclasts
Large multinucleated cells that arise from macrophage precursors and are specialized for bone resorption. Once firmly adhered to the bone surface, osteoclasts release hypochlorous acid and hydrolytic enzymes to digest the bone tissue.
C-type lectins
Carbohydrate-recognizing proteins (lectins) that require Ca 2+ ions for their proper function. A characteristic feature of their structure is a carbohydrate recognition domain. C-type lectins include soluble molecules such as the complement-activating mannose binding lectin, as well as cell surface receptors such as various CLEC proteins.
Paracaspase
A group of proteolytic enzymes distinct from, but closely related to, the caspases. The most important mammalian paracaspase is MALT1.
the TCR, and this triggers kinase activation and downstream signalling. It should be noted that ZAP70 is more dependent on the SRC family kinases than SYK, probably because SYK can phosphorylate the ITAM tyrosine residues itself 8, 9 .
Signalling downstream of SYK and ZAP70. Of the several intermediate molecules implicated in relaying SYKor ZAP70-mediated downstream signalling, VAV family members, phospholipase Cγ (PlCγ) isoforms, the regulatory subunits of phosphoinositide 3-kinases (PI3Ks) and the SH2 domain-containing leukocyte protein (SlP) family members SlP76 (also known as lCP2) and SlP65 (also known as BlNK) can directly associate with SYK (FIG. 1b) and/or ZAP70. These molecules probably participate in forming receptor-proximal signalling complexes and trigger downstream processes including Ca 2+ and protein kinase C (PKC) signalling, RAS homologue (RHO) family-and protein tyrosine kinase 2 (PYK2)-mediated cytoskeletal rearrangement, reactive oxygen species (ROS) production and phagocytosis, PI3K-mediated TeC family and AKT signalling pathways, as well as transcriptional regulation through the RAS-extracellular signal-regulated kinase (eRK) and Ca 2+ -nuclear factor of activated T cells (NFAT) pathways (FIG. 1b) . Although the transmembrane adaptor protein linker for activation of T cells (lAT) is an important component of TCR and FcεRI signalling, it is at present unclear whether any lAT-related molecules have similar roles in other lineages 10 . ligation of classical immunoreceptors also triggers pro-inflammatory transcriptional programmes, through activation of nuclear factor-κB (NF-κB). Recent studies have revealed that ITAM-based signalling events lead to caspase-recruitment domain (CARD)-mediated heterotypic aggregation of CARD9 or CARMA1 (also known as CARD11) with the adaptor protein B cell lymphoma 10 (BCl-10) and the associated paracaspase mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MAlT1) [11] [12] [13] [14] [15] [16] , triggering activation of the NF-κB pathway. whereas CARMA1 relays antigen receptor-mediated activation of the BCl-10-MAlT1 complex in B cells, T cells, NK cells and mast cells, CARD9 is responsible for BCl-10-MAlT1 complex activation in macrophages and dendritic cells (DCs) [11] [12] [13] [14] [15] [16] [17] . The role of this pathway in fungal recognition will be discussed below; further details of CARMA1 and CARD9 signalling can be found in an excellent recent review 18 .
Negative regulation of SYK function. The action of SYK is often counteracted by phosphatases such as SH2 domain-containing protein tyrosine phosphatase 1 (SHP1; also known as PTPN6), and it is the balance of SYK and SHP1 activities that determines the ultimate signalling output 19 . The expression of SYK is also negatively regulated by the E3 ubiquitin ligase Casitas B-lineage lymphoma (CBl), leading to ubiquitylation and degradation of SYK [20] [21] [22] .
Box 1 | Facts and figures on SYK and SYK-related molecules
Spleen tyrosine kinase (SYK) contains two tandem SRC homology 2 (SH2) domains and a carboxy-terminal tyrosine kinase domain (see the figure). These domains are linked by two linker regions: interdomain A between the two SH2 domains and interdomain B between the C-terminal SH2 domain and the kinase domain. An alternatively spliced form of SYK (known as SYK-B) lacks 23 amino acids of interdomain B, including a nuclear localization signal 9, 185 . SYK is highly expressed by all haematopoietic lineage cells. It was initially thought to be a haematopoietic cell-specific kinase; however, later studies showed its expression in other tissues as well 145 . Although the expression of SYK is tightly regulated 30 , the mechanism of this regulation, and that leading to the generation of the SYK-B isoform, is not well understood.
Mammals also express the SYK-related molecule ζ-chain-associated protein kinase of 70 kDa (ZAP70), the expression of which is mostly confined to the T and natural killer (NK) cell lineages. Readers interested in further details of ZAP70 biology are referred to an excellent recent review 36 . SYK family kinases have an evolutionarily ancient origin but they have appeared and disappeared during the evolution of animals 186 . Drosophila melanogaster express a single SYK-related molecule, SH2 domain ankyrin repeat kinase (SHARK) 4 , which contains ankyrin-like (ANK) repeats between its two SH2 domains. Interestingly, hydras and sponges express two SYK-related kinases, one (known as HTK98) is similar to vertebrate SYK and the other (known as HTK16) is more closely related to D. melanogaster SHARK 186, 187 . By contrast, the Caenorhabditis elegans genome does not contain any SYK-related tyrosine kinases 188 .
The Syk gene has been disrupted in mice by two independent groups 23, 24 . The major phenotypes displayed by SYK-deficient mice are perinatal lethality, a petechiated in utero appearance and the lack of mature B cells. Two groups have also reported mutations allowing the Cre-mediated conditional deletion of Syk 189, 190 . To the best of our knowledge, no human patients or animal strains with a spontaneous germline mutation in SYK have been described. 
E3 ubiquitin ligase
An enzyme that is required to attach the molecular tag ubiquitin to proteins. Depending on the position and number of ubiquitin molecules that are attached, the ubiquitin tag can target proteins for degradation by the proteasome, sort them to specific subcellular compartments or modify their biological activity.
Pro-B cells
Cells in the earliest stage of B cell development in the bone marrow. They are characterized by incomplete immunoglobulin heavy-chain rearrangements and are defined as CD19 + cytoplasmic IgM -or sometimes as B220 + CD43 + (by the Hardy classification scheme).
Pre-B cells
Cells in a stage of B cell development in the bone marrow that are characterized by complete immunoglobulin heavy-chain rearrangement in the absence of immunoglobulin light-chain rearrangement. They express the pre-B cell receptor, which comprises a pseudo light chain and a heavy chain.
The role of SYK and ZAP70 in leukocyte function. As B cell and T cell development require signal transduction by properly rearranged antigen receptors, SYK deficiency leads to complete absence of mature B cells 23, 24 , and ZAP70-deficient humans and mice have severe defects in T cell development [25] [26] [27] . More detailed studies have revealed that SYK has an important, although not indispensable, role in the transition of pro-B cells into pre-B cells, and is essential for immature B cells to pass a recently described RAC-dependent checkpoint that Figure 1 | general mechanism of SyK-mediated signalling. a | Recruitment of spleen tyrosine kinase (SYK) or ζ-chain-associated protein kinase of 70 kDa (ZAP70) to plasma membrane receptors occurs through binding of the tandem SH2 domains of SYK or ZAP70 to two phosphorylated tyrosine residues in the receptor complex. The two phosphorylated tyrosine residues are either in a single immunoreceptor tyrosine-based activation motif (ITAM) or in two hemITAMs on two separate receptor peptide chains. The ITAMs are either present in receptor-associated transmembrane adaptors or in the cytoplasmic tail of the receptor chain itself. b | The general scheme of signal transduction through SYK is shown. Signal transduction is mostly initiated by phosphorylation of ITAM tyrosine residues by SRC family kinases. Recruitment of SYK to dually phosphorylated ITAMs triggers the activation of SYK and its direct binding to members of the VAV and phospholipase Cγ (PLCγ) families, the p85α subunit of phosphoinositide 3-kinase (PI3K), as well as SH2 domain-containing leukocyte protein 76 (SLP76) and SLP65. These direct binding partners activate downstream signalling components, which eventually trigger various cellular responses. The SYK-mediated signalling pathways are also regulated by several feedback mechanisms, such as the phosphorylation of ITAM tyrosine residues by SYK or the regulation of direct SYK binding partners by further downstream molecules. SYK activation by hemITAM-containing receptors probably proceeds through similar mechanisms. BCR, B cell receptor; BCL-10, B cell lymphoma 10; CARD, caspase-recruitment domain; CLEC, C-type lectin; DAG, diacylglycerol; ERK, extracellular signal-regulated kinase; FcR, Fc receptor; JNK, Janus kinase; LAT, linker for activation of T cells; MALT1, mucosa-associated lymphoid tissue lymphoma translocation protein 1; NF-κB, nuclear factor-κB; NFAT, nuclear factor of activated T cells; NLRP3, NLR family, pyrin domain-containing 3; PKC, protein kinase C; PYK2, protein tyrosine kinase 2; RASGRP, RAS guanyl-releasing protein; RHO, RAS homologue; ROS, reactive oxygen species; TCR, T cell receptor. 23, 28 . Signalling by the BCR and TCR was originally thought to be specifically mediated by SYK and ZAP70, respectively. unexpectedly, however, ZAP70 was recently found to be expressed throughout B cell development and to participate in pre-BCR signalling, and therefore also in allelic exclusion and transition from the pro-B cell stage to the pre-B cell stage 29 . Similarly, SYK was shown to have an important role in pre-TCR signalling, which occurs during the transition from the double negative 3 (DN3) to the DN4 stage of early thymocyte development 30 . Hence, SYK and ZAP70 have overlapping functions in early lymphocyte development.
SYK is also required for FcεRI signalling in mast cells 31 and FcγR signalling in neutrophils and macrophages 32, 33 , whereas FcγR-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) reactions are defective in NK cells that lack both SYK and ZAP70 (REF. 34 ). The reader is referred to excellent reviews on further aspects of these signal transduction processes 9, [35] [36] [37] [38] . ITAM-mediated 'tonic' signalling. ITAM-mediated signalling was initially thought to occur only following ligand-induced receptor cross-linking. However, recent studies revealed that the disruption of BCR signalling by inactivation of the ITAM-bearing Igα chain leads to a rapid loss of resting mature B cells 39 . These studies indicated that the maintenance of mature B cells requires ITAM-dependent constitutive ('tonic') signalling, seemingly in the absence of a BCR ligand.
It has yet to be tested whether this tonic signalling requires SYK, although the effect of SYK inhibitors on BCR-expressing B cell lymphomas suggests that this is the case (see below).
Recent studies have also revealed antigen-independent signal transduction by FcεRI on mast cells 40, 41 . As these responses require receptor aggregation and SYK, they seem to conform to conventional ITAM-SYK-mediated signalling.
Signalling by hemITAM-containing C-type lectins. It has long been thought that the two phosphorylated tyrosine residues have to reside in a single peptide chain (as in a classical ITAM) to recruit and activate SYK. However, a new family of C-type lectins, including the fungal recognition receptor CleC7A (also known as dectin 1) or the platelet receptor CleC2 (also known as CleC1B) can activate SYK even though these receptors only have a single Tyr-X-X-leu motif (termed 'hemITAM') in their cytoplasmic tail 42, 43 . Further studies provide support for the role of the tyrosine residue in the Tyr-X-X-leu motif, as well as both SYK SH2 domains, in signal transduction 43, 44 , which suggests that hemITAM-containing C-type lectins activate SYK by dimerization followed by engagement of the two SH2 domains of SYK by phosphorylated hemITAMs on two separate receptor chains (FIG. 1a) . evidence for this stoichiometry has recently been provided for the CleC2-SYK interaction 45 . The functional role of SYK in signalling by C-type lectins is discussed below; other aspects of these receptors can be found in excellent recent reviews 7, 46 .
Structural basis of SYK function
Three different SYK activity states. Immunoreceptor signalling through SYK requires the kinase activity of SYK, as well as both SH2 domains. The kinase domain of SYK is inactive in the resting state of the protein but can be activated by binding of both SH2 domains to dually phosphorylated ITAMs (FIG. 2b) . Phosphorylation of tyrosine residues in the linker regions (interdomain A or B) also results in kinase activation even in the absence of phosphorylated ITAM binding (see below). This observation led to the proposal that SYK functions as an 'OR' logic gate switch 47 (FIG. 2b) . The physiological relevance of this activation is discussed below.
Autoinhibition of the kinase domain. Although no high resolution three-dimensional structure of the entire SYK protein is available, the structure for the related protein ZAP70 indicates that the kinase adopts an autoinhibited conformation in the absence of phosphorylated ITAM binding 48, 49 . In this structure, binding between interdomain A, interdomain B and parts of the kinase domain hold the catalytic centre in an inactive conformation. engagement of the SH2 domains by a phosphorylated ITAM disassembles this tripartite binding, allowing the kinase domain to adopt an active conformation.
Several studies indicate that, analogous to ZAP70, SYK is also regulated by similar autoinhibition (FIG. 2b) . A low resolution three-dimensional structure of SYK shows that SYK has a compact structure, similar to autoinhibited ZAP70 (REF. 50 ). Deletion of both SH2 domains, or of interdomain A alone 51, 52 , as well as binding of a phosphorylated ITAM to the SH2 domains 52 , results in SYK activation, consistent with it being relieved from an autoinhibited conformation.
Interaction of SYK with phosphorylated ITAMs.
Binding of the SH2 domains of SYK to phosphorylated ITAMs is a crucial step in SYK activation and downstream signalling. A high-resolution three-dimensional structure of the SH2 domains of SYK in complex with the doubly phosphorylated ITAM of CD3ε showed that the amino-terminal SH2 domain binds to the carboxy-terminal phosphorylated tyrosine of the ITAM and vice versa 53 (FIG. 1a) . The structure shows substantial flexibility 53, 54 , which might account for the ability of SYK, in contrast to ZAP70, to bind to phosphorylated ITAMs with a broad range of spacing between the phosphory lated tyrosine residues (including the longspaced FcγRIIA ITAM 55 ) and to bridge two hemITAMs in C-type lectins [43] [44] [45] (FIG. 1a) .
The role of phosphorylated tyrosines in SYK. There are ten tyrosine residues in SYK that are sites of autophosphorylation 56 . Phosphorylated Tyr317 is a binding site for the e3 ubiquitin ligase CBl (FIG. 2a) , which is involved in the ubiquitylation and degradation of SYK 20, 21 . Accordingly, mutation of this residue results in enhanced FcεRI-and BCR-mediated signalling 59, 60 . Phosphorylated Tyr317 also binds to the C-terminal SH2 domain of the PI3K regulatory subunit p85α, whereas the N-terminal SH2 domain of p85α binds phosphorylated Tyr342 and phosphorylated Tyr346 (REF. 61) (FIGS 2a,c). Mutation of all three tyrosine residues abrogates FcεRI-induced AKT activation, consistent with an inability to activate PI3K 62 .
In the ZAP70 structure, Tyr315 and Tyr319 in interdomain B and Tyr597 and Tyr598 in the kinase domain stabilize the autoinhibited conformation 48 . Mutation of these residues in ZAP70 or of the analogous residues in SYK (Tyr342, Tyr346, Tyr624 and Tyr625) results in kinase activation, further indicating that SYK adopts an autoinhibited conformation [63] [64] [65] . All four residues are phosphorylated following BCR stimulation 56 , probably contributing to kinase activation by destabilizing the autoinhibited conformation of SYK (FIG. 2b) , as well as providing docking sites for other signalling molecules that stabilize the active conformation and initiate downstream signalling (FIG. 2c) .
Phosphorylated Tyr342 binds to the SH2 domain of VAV1 and both phosphorylated Tyr342 and phosphorylated Tyr346 bind to the C-terminal SH2 domain of PlCγ1 (REFS 66,67) (FIGS 2a,c). Interestingly, binding of PlCγ1 is mediated by two phosphorylated tyrosine residues binding to one SH2 domain 68 . Mutation of these residues inhibits FcεRI signalling in mast cells 62, 69 and phenocopies the cytoskeletal changes observed in SYK-deficient neutrophils 70 . when phosphorylated, Tyr624 binds to the SH2 domain of SlP65 (REF. 71 ) (FIGS 2a,c). This binding activates the kinase, which is consistent with the putative role of Tyr624 in stabilizing the autoinhibitory conformation. This SlP65-SYK association is also important for BCR signalling and B cell development 71 . Although no direct interaction between Tyr624 and the SlP65-related adaptor SlP76 has been reported, such a direct functional association would not be surprising given the strikingly similar phenotypes of SYK-deficient 3, 23, 24, 33, 72, 73 and SlP76-deficient mice 3, 74, 75 .
Integration of SYK activation. The most likely physiological relevance of the dual activation of SYK either by ITAM binding or by phosphorylation of tyrosine residues in the linker regions is that initial ITAM binding triggers rapid activation of SYK, whereas subsequent phosphorylation leads to prolonged activation and downstream signalling even in the absence of binding to phosphorylated ITAMs (FIG. 2c) . Importantly, SYK can catalyse the autophosphorylation of its linker region tyrosine residues, leading to sustained SYK activation after transient ITAM phosphorylation. In addition, SYK itself can phosphorylate ITAMs, suggesting the existence of a positive feedback loop during initial ITAM-mediated SYK activation 52 (FIG. 2c) . Proteins shown to bind to phosphorylated tyrosines are indicated above the tyrosine residues (p85α represents the 85 kDa phosphoinositide 3-kinase (PI3K) regulatory subunit). b | There are three different states of SYK activation. SYK is autoinhibited in its resting state owing to the binding of interdomain A and interdomain B to the kinase domain, in particular, the carboxy-terminal end. This autoinhibited conformation can be suspended by binding of the two SH2 domains to dually phosphorylated immunoreceptor tyrosine-based activation motifs (ITAMs) or by phosphorylation of tyrosine residues in interdomain A or B. There is a logic 'OR' relationship between those two activation mechanisms. c | Prior to activation, SYK is held in an autoinhibited conformation by interactions between interdomains A and B and the kinase domain. Initial phosphorylation of ITAM tyrosine residues by SRC family kinases provides docking sites for the SYK SH2 domains inducing conformational changes and kinase activation. SYK activation results in autophosphorylation on several residues, leading to release from the ITAM and sustained SYK activation. SYK then recruits direct binding partners to its phosphorylated tyrosine residues, triggering downstream signalling. Phosphorylation of ITAM tyrosines by SYK provides a positive feedback loop. Amino acid numbers in this figure correspond to the sequence of mouse SYK. CBL, Casitas B-lineage lymphoma; PLCγ, phospholipase Cγ; SLP65, SH2 domain-containing leukocyte protein of 65 kDa.
Phosphomimetic
An amino acid of which the conformation resembles that of a phosphate residue, or that of the phosphorylated form of another amino acid. Owing to their negative charge, the most important phosphomimetic amino acids are glutamate and aspartate.
Vasculopathy
A disorder of blood vessels, such as inflammation of the vessel wall.
Heterologous expression systems
An experimental approach that relies on forced expression of a protein in cells (usually long-propagated cell lines). The approach is powerful but can lead to artefactual results owing to the expression of proteins in a 'unnatural' environment.
Slow rolling
The reduction of leukocyte rolling velocity in an inflammatory environment. Under normal conditions, leukocytes roll on the surface of endothelial cells at a speed of ~40 μm per second, mainly determined by the low level expression of endothelial P-selectins. At sites of inflammation, E-selectins are expressed at high densities on the endothelial surface, leading to slowing down of the rolling cells to ~5 μm per second.
Inside-out signalling
The process by which intracellular signalling mechanisms result in the activation of a cell surface receptor, such as integrins. By contrast, outside-in signalling is the process by which ligation of a cell surface receptor activates signalling pathways inside the cell.
The role of SYK in cell adhesion Integrin signal transduction. Integrins are a family of heterodimeric transmembrane receptors that participate in leukocyte adhesion and migration (through lymphocyte function-associated antigen 1 (lFA1; also known as αlβ2 integrin) and macrophage receptor 1 (MAC1; also known as αMβ2 integrin)), platelet activation (through αIIbβ3 integrin) and osteoclast development and function (through αVβ3 integrin). Given their structural and functional differences, integrins and classical immunoreceptors were long thought to signal by conceptually different mechanisms.
evidence for the use of similar signalling mechanisms by integrins and immunoreceptors came from studies showing defective integrin-mediated signalling in SYKdeficient neutrophils 72 , monocytes, macrophages 76, 77 , platelets 73 and osteoclasts 78 . Further in vivo studies showed that SYK is necessary for firm leukocyte adhesion to the inflamed endothelium 79 and the development of a MAC1-dependent vasculopathy reaction 80 . The mechanism of SYK activation by integrins has long been debated, mainly because initial studies in heterologous expression systems indicated that αIIbβ3 integrin activates SYK by an ITAM-independent mechanism through direct association between the cytoplasmic tail of the integrin β-chain and the non-ITAM-binding surfaces of the N-terminal SH2 domain of SYK [81] [82] [83] (FIG. 3a) .
More recent analyses of primary cells (rather than heterologous expression systems) came to a different conclusion. Structure-function studies indicated a crucial role of phosphorylated tyrosine binding by the SH2 domains of SYK for integrin-mediated functions in neutrophils, macrophages and platelets 77, 84 . The ITAMcontaining proteins that link β2 integrin signalling to SYK activation in neutrophils and macrophages have been identified as the transmembrane adaptor molecules DAP12 (also known as TYROBP) and the FcR γ-chain (FcRγ) 77 (FIG. 3b) . later studies indicated that integrin signalling in osteoclasts 85 , DCs 86 , microglia 87 and platelets 88 also require ITAM-containing transmembrane adaptors. However, the coupling between integrins and the ITAM-containing adaptor molecules is poorly understood, despite preliminary studies 77 suggesting the involvement of as yet unidentified DAP12-associated molecules (FIG. 3b) .
Importantly, the ITAM-independent 81,84 and ITAMmediated 77,84-88 mechanisms of integrin-SYK coupling are not mutually exclusive. Indeed, the most likely scenario is that the two mechanisms jointly regulate the activity of SYK 6, 85 (FIG. 3c) , allowing the fine control of adhesive interactions of haematopoietic lineage cells. It should also be noted that whereas SYK is crucial for several integrinmediated functions, it makes a limited contribution to β2 integrin-mediated migration of neutrophils 70, 72 .
Leukocyte selectin functions. Selectins are transmembrane glycoproteins that are involved in leukocyte rolling on the endothelium. endothelial P-selectins mediate steady-state leukocyte rolling, whereas slow rolling in an inflammatory environment is triggered by endothelial e-selectins. Recent evidence from two studies 89, 90 indicates a role for SYK in signal transduction by P-selectin glycoprotein ligand 1 (PSGl1), the major selectin receptor on leukocytes. SYK is activated by, and associates with, PSGl1 in leukocytes 89, 90 . Abrogation of SYK activity inhibits PSGl1-mediated transcriptional regulation 89 , whereas SYK-deficient neutrophils show a defect in slow rolling, suggesting that SYK is involved in PSGl1-induced inside-out signalling that activates lFA1 (REF. 90) (FIG. 3d) . Both studies concluded that PSGl1-induced SYK activation proceeds through an ITAM-mediated pathway 89, 91 . However, one report suggested that SYK is activated through the ITAM-like motif-containing ezrin, radixin and moesin (eRM) family proteins 89 , whereas the other study suggested that phosphorylation of the ITAMbearing adaptors DAP12 and FcRγ by the SRC family kinase FGR is involved 91 (FIG. 3d) .
The role of SYK in innate pathogen recognition The innate immune system uses germline-encoded pattern recognition receptors (PRRs) to detect pathogenassociated molecular patterns (PAMPs) and activate immune responses. Recently, SYK has been found to be a key component of these pathways (FIG. 4a) .
Recognition of fungi.
The first insights into SYKdependent PRR signalling came from studies of the C-type lectin CleC7A, an important mammalian PRR for fungal β-glucans 43 with a hemITAM in its intra cellular tail (FIG. 4a) . Agonist binding to CleC7A triggers hemITAM phosphorylation, resulting in direct recruitment of SYK to CleC7A. As with other hemITAM-containing C-type lectins, CleC7A-mediated SYK activation requires a single tyrosine residue in a Tyr-X-X-leu motif. It is reasonable to assume that two hemITAM-phosphorylated CleC7A molecules engage the tandem SH2 domains of a single SYK molecule in a 2/1 stoichiometry 7 , as has recently been shown for the CleC7A-related receptor CleC2 in platelets 45 . SYK-mediated signalling following CleC7A ligation triggers ROS production 92, 93 and phagocytosis of yeast particles by DCs 43 . Moreover, SYK couples PAMP recognition to de novo gene transcription and induces chemokine and cytokine production through several downstream pathways, including the eRK signalling cascade and activation of transcription factors such as NFAT 94 and NF-κB 11, 43, 93, [95] [96] [97] . Although the precise mechanisms of SYK-mediated phagocytosis and ROS production are not well understood, the CleC7A-SYK-induced NF-κB response is transduced through CARD9, which engages BCl-10 and MAlT1 (REFS 11, 98, 99) (FIG. 4b) . Consistent with an essential role of the CleC7A-SYK-CARD9 axis for anti fungal host defence, CARD9-deficient mice and humans are highly susceptible to fungal infections 11, 100 . At present, it is unclear how SYK activates CARD9, but this mechanism probably differs from the PKC-mediated activation of CARMA1 in lymphocytes as the crucial PKC phosphory lation sites of CARMA1 are not conserved in CARD9 (REF. 18 ). Moreover, the specific role of SYKtriggered eRK or NFAT activation in antifungal immunity has not yet been defined. Inflammasome activation. Il-1β is a SYK-dependent cytokine with an essential role in antifungal immunity 93 . Production of mature Il-1β requires NF-κB-mediated transcription of pro-Il-1β and proteolytic processing of pro-Il-1β by caspase 1-containing multiprotein complexes termed inflammasomes
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. live yeast cells specifically activate This signalling probably involves DAP12-and/or FcRγ-associated transmembrane receptors. c | In the combined model, the non-phosphorylated tyrosine-binding surface of the SYK SH2 domains bind to the carboxy-terminal end of the integrin β-chain, whereas the two SH2 domains bind to the phosphorylated ITAM tyrosine residues. d | Ligation of leukocyte P-selectin glycoprotein ligand 1 (PSGL1) triggers phosphorylation of the ITAM tyrosine residues of ITAM-like motif-containing ezrin, radixin and moesin (ERM) family proteins, which recruit SYK through its tandem SH2 domains. A supposedly parallel mechanism under flow conditions leads to phosphorylation of the ITAM tyrosine residues of DAP12 and FcRγ by the tyrosine kinase FGR, leading to the recruitment of SYK through its tandem SH2 domains. SYK activation triggers transcriptional changes and inside-out activation of lymphocyte function-associated antigen 1 (LFA1). the NlR family, pyrin domain-containing 3 (NlRP3) inflammasome 93 . SYK controls both pro-Il-1β synthesis and NlRP3 activation in response to fungal infection 93 . whereas pro-Il-1β synthesis is regulated through the SYK-CARD9 pathway, NlRP3 activation occurs through a SYK-dependent but mostly CARD9-independent mechanism 93 (FIG. 4b) . b | The mechanism of pro-inflammatory responses triggered by recognition of fungal pathogens by C-type lectins is illustrated. CLEC7A binds SYK directly through an intracellular hemITAM, whereas CLEC6A and CLEC4E engage SYK through FcRγ. Pathogens trigger SYK-mediated phagocytosis, cytokine and chemokine production, and ROS generation. SYK-mediated nuclear factor-κB (NF-κB) signalling is controlled by the CARD9-BCL-10-MALT1 complex. In addition, SYK is required for interleukin-1β (IL-1β) processing by the NLR family, pyrin domain-containing 3 (NLRP3) inflammasome, which is activated by SYK-dependent reactive oxygen species (ROS) production, K + efflux and presumably additional unknown danger signals. ASC, adaptor protein apoptosis-associated speck-like protein containing a CARD; BCL-10, B cell lymphoma 10; CARD9, caspase-recruitment domain 9; DC, dendritic cell; MALT1, mucosa-associated lymphoid tissue lymphoma translocation protein 1; TDM, trehalose 6,6ʹ-dimycolate.
Monosodium urate
A monosodium salt of uric acid that has a tendency to precipitate in needle-shaped crystals in the joints, leading to the inflammatory disease gout.
unidentified components are probably also required for the activation of the NlRP3 inflammasome following yeast infection (FIG. 4b) .
Recognition of bacteria and viruses.
There is increasing evidence that SYK-coupled PRRs also have important roles in innate recognition of bacteria, with CleC7A, CleC6A and CleC4e all implicated in sensing of mycobacterial PAMPs 46 (FIG. 4a) . Although the mycobacterial structures that are recognized by CleC7A and CleC6A remain to be identified, CleC4e has been reported to be the long-sought receptor for the mycobacterial cord factor trehalose 6,6ʹ-dimycolate (TDM), the most thoroughly studied immune stimulant of Mycobacterium tuberculosis 107, 111 . Myeloid cell activation by TDM, or its less toxic analogue trehalose 6,6ʹ-dibehenate, uses ITAM-SYK signalling through FcRγ, SYK and the CARD9-BCl-10-MAlT1 complex 106, 107 . In addition to CleC7A, CleC6A and CleC4e, there are more myeloid C-type lectin receptors with as yet unidentified functions 46 , and other innate immune receptors have also been proposed to signal through SYK 112 . Furthermore, genetic deletion of SYK has been shown to attenuate antibacterial host defence in mice 113 . Dengue virus is detected by the C-type lectin CleC5A (also known as MDl1), which induces pro-inflammatory cytokine production through DAP12 (REF.. 114) (FIG. 4a) . Therefore, SYK is presumably also involved in signalling PRR-mediated recognition of certain viruses.
Signalling tissue damage
The innate immune system is also activated by noninfectious stimuli, such as cell death caused by sterile injury or developmental processes, or sterile inflammation during autoimmune diseases.
There is accumulating evidence that SYK-coupled C-type lectins can detect host-derived molecules from damaged cells. CleC4e, an FcRγ-associated fungal and mycobacterial PRR (see above), can sense necrotic cells after prolonged culture in vitro 115 , and it is reasonable to assume that this response also requires the ITAMmediated activation of SYK (FIG. 4a) . The CleC4e ligand expressed by necrotic cells has been identified as spliceosome-associated protein 130 (SAP130) 115 . A second SYKcoupled receptor for recognition of dead cells is CleC9A (also known as DNGR1). like CleC7A, CleC9A has a cytoplasmic hemITAM with a single Tyr-X-X-leu motif (FIG. 4a) . CleC9A is highly expressed by subsets of DCs and monocytes and recognizes as yet unidentified ligands that are exposed during cell necrosis 116 . CleC9A promotes DC-mediated cross-presentation of dead cell-derived antigens through a hemITAM-SYK interaction 117 . The ITAM or hemITAM-SYK-mediated damage recognition pathway is probably an ancient mechanism as it is also found in invertebrates. The clearance of neuronal cell corpses by phagocytic glial cells in the brains of D. melanogaster requires Draper, an ITAM-containing phagocytic receptor 118 (FIG. 4a) .
Draper ligation by phagocytic targets triggers ITAM phosphory lation by the SRC-related kinase SRC42A, leading to subsequent association with the SYK-related kinase SH2 domain ankyrin repeat kinase (SHARK) (FIG. 4a) , which is essential for Draper function in glial cells in vivo 4 . Taken together, these pathways indicate that the ITAM-SYK-mediated damage recognition pathway is an ancient mechanism that it shared between insects and mammals and that this pathway overlaps with innate recognition of pathogens.
Other immune functions of SYK SYK has been implicated in several other signalling pathways in immune cells. The DAP12-associated triggering receptor expressed on myeloid cells (TReM) family molecules participate in several inflammation-related biological processes, including modulation of Toll-like receptor function, through activation of SYK 119 . CleC4C (also known as BDCA2), an FcRγ-associated receptor expressed on DCs, also signals through SYK but, in contrast to C-type lectins involved in pathogen recognition, it does not activate NF-κB SYK and DAP12 have been implicated in signalling from the colony-stimulating factor 1 receptor (also known as FMS) in an ITAM-dependent manner also requiring PYK2 (REFS 78, 122) . MHC class II molecules on B cells associate with, and trigger the phosphorylation of, the ITAM-bearing Igα and Igβ adaptors 123 . NK cells express SYK and ZAP70, both of which are involved in FcγR-mediated ADCC responses 34 . NK cells also express the ITAM-bearing transmembrane adaptor DAP12, which is coupled to several activating NK cell receptors. However, although SYK and/or ZAP70 are required for calcium signalling and cytokine release following activation of DAP12-associated receptors 124, 125 , NK cells lacking both SYK and ZAP70 can kill target cells through a DAP10-and PI3K-mediated parallel pathway 125, 126 . Crystals of monosodium urate activate DCs by a receptor independent pathway 127 , which involves aggregation of cholesterol and activation of a SYK-dependent signalling pathway. The mechanism of this activation is incompletely understood, but might involve the recruitment of ITAM-associated receptors. Importantly, this mechanism may contribute to the development of crystal-induced diseases such as gout.
SYK had also been proposed to participate in G protein-coupled receptor signalling 128 . However, genetic studies of this pathway in neutrophils and mast cells 128 argue against that possibility.
Non-immune functions of SYK Although ITAM-SYK signalling has long been regarded to be specific for the immune system, recent studies indicate several non-immune functions of SYK.
Receptor activator of NF-κB (RANK)
. A cytokine receptor that is closely related to tumour necrosis factor receptors and that is mainly expressed by osteoclast lineage cells. Ligation of RANK on early macrophage precursors by RANK ligand expressed on osteoblasts triggers re-programming of the cell leading to osteoclast development.
Osteoblasts
Bone-lining fibroblast-related cells of non-haematopoietic origin that are specialized for the generation of bone matrix and the regulation of bone metabolism. Through expression of RANK ligand, they also promote the development and activation of osteoclasts.
Nasu-Hakola disease
(Also known as polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL)). An inherited human disease characterized by presenile dementia and bone cysts. It is caused by loss of function mutations in the ITAM-containing adaptor protein DAP12 or the DAP12-associated receptor TREM2. The clinical manifestations probably result from the loss of DAP12 or TREM2 in osteoclasts and microglial cells.
Osteopetrosis
A rare inherited disease characterized by pathological accumulation of mineralized bone matrix in the bones. Despite the increased bone mass, osteopetrotic bones are fragile owing to abnormal bone composition and structure. It is caused by a lack or dysfunction of osteoclasts and therefore can be cured by bone marrow transplantation.
Haemostasis
The combination of events that result in cessation of bleeding. Haemostatic processes include constriction of blood vessels, platelet aggregation and coagulation (clotting) of the blood.
Bone metabolism. Osteoclasts are macrophage-related bone-resorbing cells that develop from early myeloid precursors under the control of the TNF-related protein receptor activator of NF-κB (RANK) ligand expressed by osteoblasts. Differentiated pre-osteoclasts fuse to form large multinucleated cells, which then bind to and resorb the bone surface. Importantly, αVβ3 integrin participates in diverse functions of osteoclasts, including sealing the resorption area from the surrounding environment. loss of function mutations of DAP12 cause bone abnormalities in humans (Nasu-Hakola disease) 129 , which indicates a possible role of ITAM-based signalling in bone metabolism. Indeed, DAP12-deficient mice show moderate osteopetrosis 130, 131 , whereas mice lacking both DAP12 and FcRγ show severe osteopetrosis 5, 132 . Although FcRγ is involved in osteoblast-osteoclast interactions, DAP12 is responsible for relaying an osteoblast-independent signal 5, 132 (FIG. 5a) .
Importantly, SYK, which is activated downstream of DAP12 and FcRγ in an ITAM-dependent manner, is also required for osteoclast development and function 5, 85, 133 ( FIG. 5a) . Although the precise mechanism of DAP12 and FcRγ activation is poorly understood, it probably involves the FcRγ-associated receptors osteoclast-associated receptor (OSCAR) and paired immunoglobulin-like receptor A (PIRA), and the DAP12-associated molecule TReM2 (REF. 132) (FIG. 5a) . This ITAM-mediated pathway has been proposed to be a co-stimulatory pathway for RANK ligand signalling 132 , as well as a mediator of αVβ3 integrin signal transduction 5, 85 (FIG. 5a) .
Platelet functions. Several platelet functions rely on SYK signalling. GPVI, a major collagen receptor of platelets, is an FcRγ-associated receptor that is closely related to FcαRs, which may explain why GPVI, similar to other FcR family members, signals through SYK 2 (FIG. 5b) . The C-type lectin CleC2 has also been shown to signal through SYK in platelets 42 . Similar to other hemITAM-containing receptors, CleC2 has a single cytoplasmic Tyr-X-X-leu motif which engages both SH2 domains of SYK by dimerization of the receptor 45 (FIG. 5b) . SYK also mediates outside-in signalling by αIIbβ3 integrin on platelets 73 . The mechanism of SYK activation by αIIbβ3 integrin was shown to be ITAM dependent 84 (see above) and to require, at least in human cells, the ITAM-containing FcγRIIA molecule 88 (FIG. 5b) . As CleC2 (REF. 134 ) and the SYK substrate SlP76 (REF. 135 ) are required for arterial thrombus formation, it is likely that SYK also participates in in vivo functions of platelets during haemostasis.
Vascular development.
One of the most striking phenotypes of SYK-deficient fetuses is the appearance of bloodfilled subcutaneous structures originally described as petechial haemorrhages 23, 24 but later identified as bloodfilled lymphatic vessels 3 , and this indicated that SYK is required for the separation of lymphatic vessels from the general circulation. Surprisingly, this vascular defect could be transferred to lethally irradiated wild-type recipients by bone marrow transplantation 33 , indicating a role for SYK expression by the haematopoietic compartment. Two subsequent studies proposed different explanations, suggesting either that the defect lies in circulating endothelial progenitor cells (which share their origin with true blood cells) 136 or that the vascular phenotype is due to a gain of function effect, whereby tissue accumulation of Syk -/-myeloid cells leads to excessive release of pro-angiogenic factors that trigger hyperproliferation of the lymphatic vasculature 137 . However, the mechanism attributable to the circulating endothelial progenitor cells contradicts the lack of SYK expression in the endothelial cell lineage 137 , whereas the gain of function mechanism does not seem to explain the correction of the vascular phenotype by the presence of only 5-10% wild-type cells in the haematopoietic compartment in mixed bone marrow chimaeras 3 . A series of recent studies propose an exciting third explanation (FIG. 5c ). Blood and lymph vessels fail to separate in platelet-deficient fetuses 138 , as well as in mice lacking either the platelet receptor CleC2 (REF. 139) or the CleC2 ligand podoplanin, which is expressed on lymphatic (but not blood) endothelial cells [139] [140] [141] . A similar vascular phenotype is also induced by platelet-specific deletion of SlP76 (REF. 139) (the deficiency of which also leads to a blood-lymphatic vascular separation defect (FIG. 5b) , these results suggest that podoplanin on lymphatic endothelial cells triggers platelet activation and aggregation through CleC2, SYK, SlP76 and PlCγ2 (FIG. 5b,c) , thereby closing off any blood-lymphatic shunts by a yet unidentified mechanism that possibly involves platelet aggregation. As a consequence, newly formed lymphatic sacks are separated from the blood vasculature, and a long-term incompatibility between the two vascular systems is established.
Other non-haematopoietic functions. SYK is also expressed by cells of non-haematopoietic origin including normal mammary glands and mammary gland epithelial cell lines 143 , as well as various other tissues (reviewed in REFS 144, 145) . Although studies have proposed that SYK has a role in processes including signalling by integrins and TNF receptors, transcriptional regulation and mitotic progression in these cells (reviewed in REF.144 ), this area is still poorly understood with little mechanistic information available.
A SYK-related kinase has also been proposed to participate in gonadal development in the parasitic helminth Schistosoma mansoni 146 , suggesting that the role of SYKrelated kinases in non-haematopoietic tissues may also have an ancient evolutionary origin.
SYK in disease pathogenesis and therapy
Allergy and autoimmunity. The diverse roles of SYK in the immune system suggest that it might participate in allergic and/or autoimmune diseases. Indeed, SYK-deficient bone marrow chimaeras are protected from reverse passive Arthus reaction 70 and autoantibody-mediated experimental arthritis 147 . A supposedly SYK-selective inhibitor, R112 (Rigel), alleviates the symptoms of allergic rhinitis in Nature Reviews | Immunology 
Reverse passive Arthus reaction
An antibody-mediated local hypersensitivity reaction that is triggered by systemic injection of antigen followed by local (subcutaneous) injection of antibody against the injected antigen. The formation of immune complexes results in local oedema and inflammation, which is mediated by Fc receptors and activation of the complement cascade.
human patients 148 . An R112-related inhibitor, R406 (Rigel), as well as its orally bioavailable prodrug, fostamatinib (R788; Rigel/Astra Zeneca), delayed the onset and reduced the severity of autoimmune arthritis in animal models 149, 150 and provided clinical benefit in patients with rheumatoid arthritis 151 . More recently, fostamatinib has shown beneficial effects in autoantibody-induced thrombocytopenia in mice, and autoimmune thrombocytopenic purpura in humans 152 . Various aspects of the mechanism of action of SYK inhibitors in clinical use are discussed in BOX 2. In addition to a receptor activator of NF-κB (RANK)-RANK ligand interaction, osteoblasts express yet unidentified ligands that engage a putative FcRγ-associated receptor (most likely osteoclast-associated receptor (OSCAR) or paired immunoglobulinlike receptor A (PIRA)) on the osteoclast surface. Osteoclasts also express putative DAP12-associated receptors (most likely triggering receptor expressed on myeloid cells 2 (TREM2)), which bind to yet unidentified ligands that are not expressed by osteoblasts. Both FcRγ and DAP12 promote osteoclast development and function through immunoreceptor tyrosine-based activation motif (ITAM)-mediated spleen tyrosine kinase (SYK) activation and the phospholipase Cγ2 (PLCγ2)-calcineurinnuclear factor of activated T cells, cytoplasmic 1 (NFATc1) pathway. b | SYK-mediated signalling in platelets is illustrated. Collagen activates the FcRγ-associated receptor glycoprotein VI (GPVI) on platelets and triggers SYK activation in an ITAM-mediated manner. The snake venom rhodocytin, endogenous podoplanin and possibly other platelet agonists activate the receptor CLEC2 (also known as CLEC1B), which recruits SYK to phosphorylated tyrosine in the CLEC2 hemITAMs with a 2/1 stoichiometry. Fibrinogen engages αIIbβ3 integrin, which associates with the ITAM-containing receptor FcγRIIA. This complex probably activates SYK through both conventional ITAM-mediated SYK activation pathways and by binding of the integrin β-chain to the amino-terminal SH2 domain of SYK in a phosphotyrosine-independent manner. All three cases of SYK activation lead to platelet activation through SH2 domain-containing leukocyte protein 76 (SLP76) and PLCγ2. c | The role of SYK in separation of blood and lymphatic vessels is illustrated. Lymphatic vessels express podoplanin which triggers platelet activation and aggregation. This and possibly other unknown mechanisms lead to closing off any blood-lymphatic shunts. The mechanism of podoplanin-mediated platelet activation involves CLEC2, which activates SYK through hemITAM phosphorylation, as well as SLP76 and PLCγ2, which function downstream of SYK.
Rhodocytin
A snake venom toxin that triggers platelet activation by binding to CLEC2 on platelets. It is a disulphide-linked heterodimer with features common to certain C-type lectins.
Haematological malignancies. SYK has been linked to the development or maintenance of haematological malignancies including B cell lineage leukaemias and lymphomas (FIG. 6) .
The first study linking SYK to a haematological malignancy described marked reduction of SYK expression in highly aggressive childhood pro-B cell acute lymphoblastic leukaemia (All) but not in more differentiated pre-B cell All 153 . As SYK is required for the transition of pro-B to pre-B cells 23 , it is tempting to speculate that the loss of SYK contributes to transformation of B cell precursors by preventing further differentiation (FIG. 6a) , as has been proposed for SlP65, the lack of which contributes to pre-B cell leukaemia in both humans and mice 154, 155 . However, the lack of an independent confirmation of SYK deficiency in pro-B cell All and the uncertainties related to extrapolating prior findings on SlP65 to SYK point to the need for further studies on the role of SYK in pro-B cell leukaemia.
SYK has different and better characterized roles in lymphomas derived from B lineage cells beyond the pro-B cell stage. Probably related to the role of SYK in promoting proliferation and blocking apoptosis in pre-B cells, exogenous expression of SYK could transform normal pre-B cells, and endogenous SYK was required for the transformation of pre-B cells by exogenous MYC 156 (FIG. 6b) . Furthermore, SYK inhibition promoted apoptosis of primary human B cell precursor All (most likely pre-B cell All) cells both in vitro and in vivo, suggesting a potential therapeutic application of SYK inhibitors in certain patients with B cell All 157 .
Transformation of mature B cells mostly leads to various forms of B cell lymphoma or B cell lineage chronic lymphocytic leukaemia (Cll). ITAM-mediated tonic BCR signalling is required for the survival of resting mature B cells and certain B cell lymphomas 39, 158, 159 . This signalling probably functions through SYK, which could explain the expression of constitutively active SYK in B cell lymphomas and B cell lineage Cll cells [160] [161] [162] . SYK is also required for processing stromal cell-derived pro-survival signals, such as adhesion and homing, by Cll cells independently of BCR signalling 163 . These results suggest that SYK contributes to the survival and maintenance of B cell malignancies (FIG. 6d) . Accordingly, abrogation of SYK activity inhibited the growth of various B cell lymphomas 160, 164, 165 , and fostamatinib therapy prolonged the survival of patients with diverse types of B cell lymphoma or B cell lineage Cll 166 . SYK might also participate in haematological malignancies of non-B cell origin. T cell lymphomas often overexpress enzymatically active SYK 167 , may contain chromosomal translocations leading to the expression of an Il-2-inducible T cell kinase (ITK)-SYK fusion protein 168 and are sensitive to silencing of SYK expression 169 . A chromosomal translocation generating a Tel-SYK fusion protein causes myelodysplastic syndrome, a pre-leukaemic state that predisposes to the development of acute myeloid leukaemia 170 , and SYK seems to be an important component of disease pathogenesis in acute myeloid leukaemia itself 171 . These results may further extend the possible use of SYK inhibitors in human therapy.
SYK signalling by viral oncogenes. SYK is also required for the oncogenic activity of several viruses that encode ITAM-containing proteins 172 . The ITAM of the viral protein latent membrane protein 2A (lMP2A) and host cell SYK are both required for epstein-Barr virus-induced oncogenic transformation 173, 174 . Similarly, the ITAMbearing envelope protein of mouse mammary tumour virus contributes to virus-induced transformation in an ITAM-and SYK-dependent manner 175, 176 . Furthermore, the ITAM-containing K1 protein of Kaposi's sarcomaassociated herpesvirus initiates ITAM-and, presumably, SYK-dependent signalling pathways to promote lytic viral replication in infected B cells 177, 178 . The possible role of these and other viruses in breast cancer 179 raise the possibility of a tumour-promoting role for SYK in certain tumours.
Other non-haematopoietic tumours. In contrast to a possible tumour-promoting role for SYK in virus-induced tumours, it has been proposed to suppress the growth of other (supposedly non-virus-induced) tumours of non-haematopoietic origin. SYK expression inversely correlated with invasiveness in breast cancer cell lines 143 and exogenous expression of SYK inhibited tumour growth, whereas expression of a dominant-negative SYK was found to promote tumorigenesis 143 . SYK expression also inversely correlated with the severity of breast cancer and other epithelial cell-derived tumours in human patients 143, 144, [180] [181] [182] , with particularly poor prognosis when low nuclear levels of SYK were present 183, 184 .
Box 2 | What is the mechanism of action of SYK inhibitors in clinical use?
Spleen tyrosine kinase (SYK) inhibitors have shown positive results in the treatment of allergy 148 , autoimmune diseases 151, 152 and B cell lineage malignancies 166 , but the mechanism of their action is incompletely understood. This is in part due to the diverse roles of SYK in immunological functions. For example, B cell-mediated antigen presentation and autoantibody formation, Fc receptor-mediated myeloid cell functions and β2 integrin-mediated leukocyte activation have all been implicated in the pathogenesis of rheumatoid arthritis and they all have been shown to require SYK (see REF. 147 for further details). The rapid effects of R112 (Rigel) treatment in allergic rhinitis 148 and the effectiveness of SYK inhibitors in autoantibody-induced passive models of arthritis 149 and autoimmune thrombocytopenia 152 also suggest that SYK inhibitors target disease components other than B cell receptor (BCR)-mediated B cell functions. Likewise, although initial studies suggested that the only role of SYK in B cell lymphomas is to relay immunoreceptor tyrosine-based activation motif (ITAM)-mediated tonic BCR signalling, a recent report suggested that SYK also contributes to the survival of B cell lymphomas through processing BCR-independent adhesive and homing signals 163 . A further complicating issue is that R406, the active metabolite of the prodrug fostamatinib (R788; Rigel/Astra Zeneca), is an ATP-competitive kinase inhibitor and, similar to most such inhibitors, has rather limited specificity towards SYK. Indeed, R406 (Rigel) has been shown to inhibit several other kinases and non-kinase targets at concentrations comparable to those inhibiting SYK 149 . Of those targets, the tyrosine kinases FMS-related tyrosine kinase 3 (FLT3), KIT, LCK, Janus kinase 1 (JAK1) and JAK3, as well as the adenosine A3 receptor have been implicated in autoimmune diseases, providing additional or alternative explanations for the clinical effect of fostamatinib in human patients (see REF. 147 for further details).
Taken together, it is reasonable to assume that the clinical effects of fostamatinib are probably mediated by inhibition of several SYK-dependent and SYK-independent immune signalling pathways. Nature Reviews | Immunology The decreased level of SYK expression in cancer cells probably results from hyper-methylation of the SYK promoter, rather than mutations or genetic deletion of SYK itself 144, 180, 182 , whereas the loss of nuclear localization of SYK is probably due to alternative splicing, leading to the expression of the SYK-B isoform, which lacks a nuclear localization signal 185 . However, it is presently unclear how loss of SYK expression results in poor prognosis in epithelial cell-derived tumours, although it may be related to any of the previously mentioned possible physiological functions of SYK in these lineages (reviewed in REF. 144 ).
Conclusions and perspective
The SYK tyrosine kinase was originally thought to only contribute to signalling responses of immunoreceptors of the adaptive immune response. However, more recent studies have identified a large number of new functions of SYK both in the immune system and beyond. Moreover, the identification of a similar pathway in D. melanogaster indicates that this signalling pathway emerged substantially earlier than the adaptive immune response. Collectively, these studies indicate that SYK has a much more diverse role in vertebrate and invertebrate biology than previously anticipated.
In addition to the diverse roles of SYK in basic biological processes, it is also involved in the pathogenesis of several human diseases, including allergy, autoimmunity and various haematological malignancies. The promising results of SYK inhibitors in recently completed human clinical trials suggest that SYK may become an important therapeutic target in those diseases in the future. 
